Protective Effects of Melatonin and Misoprostol against Experimentally Induced Increases in Intestinal Permeability in Rats

Abstract

Intestinal mucosal barrier dysfunction caused by disease and/or chemotherapy lacks an effective treatment, which highlights a strong medical need. Our group has previously demonstrated the potential of melatonin and misoprostol to treat increases in intestinal mucosal permeability induced by 15-min luminal exposure to a surfactant, sodium dodecyl sulfate (SDS). However, it is not known which luminal melatonin and misoprostol concentrations are effective, and whether they are effective for a longer SDS exposure time. The objective of this single-pass intestinal perfusion study in rats was to investigate the concentration-dependent effect of melatonin and misoprostol on an increase in intestinal permeability induced by 60-min luminal SDS exposure. The cytoprotective effect was investigated by evaluating the intestinal clearance of 51Cr-labeled EDTA in response to luminal SDS as well as a histological evaluation of the exposed tissue. Melatonin at both 10 and 100 µM reduced SDS-induced increase in permeability by 50%. Misoprostol at 1 and 10 µM reduced the permeability by 50 and 75%, respectively. Combination of the two drugs at their respective highest concentrations had no additive protective effect. These in vivo results support further investigations of melatonin and misoprostol for oral treatments of a dysfunctional intestinal barrier.

Endoplasmic reticulum stress in the pathogenesis of chemotherapy‐induced mucositis: Physiological mechanisms and therapeutic implications

“…Several studies have suggested that melatonin plays a significant role in alleviating ER‐stress across various models and conditions 74,75 . Interestingly, melatonin has been indicated to protect against surfactant‐induced, 76,77 and ethanol‐induced 78,79 increases in small intestinal mucosal permeability in rats, highlighting its potential as a treatment for a compromised intestinal mucosal barrier. While this protective effect has been shown to be primarily receptor‐mediated, 77 it could also be attributed to its pleiotropic effects on ER‐stress signaling pathways 74,75,80 .…”

A Novel Mast Cell Stabilizer JM25-1 Rehabilitates Impaired Gut Barrier by Targeting the Corticotropin-Releasing Hormone Receptors

“…The intestinal mucosa barrier plays a crucial role in preventing noxious contents of the intestinal lumen, in order to maintain systemic homeostasis [ 1 ]. The disruption of the epithelial barrier will increase intestinal permeability, leading to leaky gut syndrome [ 2 ].…”